OXYGENTAPHPharmaceuticals
Oxygenta Pharmaceutical Ltd — PE Ratio & Valuation Analysis
₹48.38
-3.44%
Current P/EN/AxPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E9.6x100.0% below avg
✅
100.0% Discount to Industry
OXYGENTAPH P/E N/Ax vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2021 | ₹2.87 | ₹28 | 9.6x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Oxygenta Pharmaceutical Ltd Valuation
Oxygenta Pharmaceutical Ltd (OXYGENTAPH) currently trades at N/Ax earnings. The Pharmaceuticals sector average PE is 31.77x. Historically, OXYGENTAPH has traded at an average PE of 9.6x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
N/A
Dividend Yield
0.00%
More on Oxygenta Pharmaceutical Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.